Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Dysmenorrhoea, Eye pain, Fatigue, Heavy menstrual bleeding, Investigation
Clinical narrative: low grade fever; had extreme changes in menstrual cycle, late, irregular, more severe pms symptoms I have never experienced before, significantly heavier flow, more painful, shorter period of time; had extreme changes in menstrual cycle, late, irregular, more severe pms symptoms I have never experienced before, significantly heavier flow, more painful, shorter period of time; had extreme changes in menstrual cycle, late, irregular, more severe pms symptoms I have never experienced before, significantly heavier flow, more painful, shorter period of time; had extreme changes in menstrual cycle, late, irregular, more severe pms symptoms I have never experienced before, significantly heavier flow, more painful, shorter period of time; had extreme changes in menstrual cycle, late, irregular, more severe pms symptoms I have never experienced before, significantly heavier flow, more painful, shorter period of time; had extreme changes in menstrual cycle, late, irregular, more severe pms symptoms I have never experienced before, significantly heavier flow, more painful, shorter period of time; had extreme changes in menstrual cycle, late, irregular, more severe pms symptoms I have never experienced before, significantly heavier flow, more painful, shorter period of time; fatigue; migraines; irritability; eye pains; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 31-years-old female patient (patient was not pregnant at the time of vaccination) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EW0179, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 09May2021 at 17:00 pm (age at vaccination was 31 years) as 2nd dose, single dose for COVID-19 immunization. The patient's medical history included asthma and chronic pain. The patient had known allergies to shellfish, cilantro, celery, carrots, parsley, cumin, dill weed and latex. Concomitant medications the patient received within 2 weeks of vaccination included lamotrigine taken for an unspecified indication. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EW0169, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 17Apr2021 at 10:30 am (age at vaccination was unknown) as 1st dose, single dose for COVID-19 immunization. The facility where the most recent COVID-19 vaccine was administered was Public Health Clinic/Veterans Administration facility. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. On 09May2021 at 20:00 pm, the patient started having a low grade fever by the end of the day of the second vaccine. The fever had been nonresponsive to most meds, acetaminophen was the only one to break the fever. She has had ongoing fevers for 32 days now. She has also had extreme changes in menstrual cycle, late, irregular, more severe PMS symptoms she had never experienced before, significantly heavier flow, more painful, shorter period of time. She had been experiencing fatigue, migraines, irritability, eye pains, as well. The patient received treatment for the adverse events and testing as per the medication advice. Since the vaccination, the patient has not been tested for COVID-19. The device date was reported as 11Jun2021. The outcome for the events was not resolved.  Information on Lot/Batch number was available. Additional information has been requested